Narcotics & CBN Compliance Services in India
The Central Bureau of Narcotics (CBN) regulates the manufacture, trade, import, and export of narcotic drugs and psychotropic substances in India under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. Compliance with CBN requirements is critical for pharmaceutical companies, research institutions, and chemical manufacturers dealing with controlled substances.
The regulatory framework for narcotics is among the most stringent in India, with serious criminal penalties for non-compliance. ACPL provides expert guidance to help legitimate businesses obtain the necessary permits and maintain ongoing compliance.
Our Services
- Import/export permit applications for narcotic drugs and psychotropic substances
- No Objection Certificates (NOCs) from CBN for controlled substance transactions
- NDPS Act compliance advisory and audit preparation
- License applications for manufacture and trade in controlled substances
- Regulatory liaison with CBN, INCB (International Narcotics Control Board), and state authorities
- Documentation and record-keeping compliance
- Controlled substance inventory management advisory
- Training programs on NDPS Act compliance for client teams
Substances Covered
CBN regulates substances listed across four schedules of the NDPS Act, including:
- Narcotic drugs — Opium, morphine, codeine, and derivatives
- Psychotropic substances — Listed under international conventions and Indian law
- Precursor chemicals — Essential chemicals used in the manufacture of narcotic drugs
- Controlled substances for research — Materials required by pharmaceutical R&D and academic institutions
Import/Export Process
Every consignment of narcotic drugs or psychotropic substances entering or leaving India requires a specific import/export permit from CBN. The process involves coordination with international regulatory bodies, customs authorities, and state drug controllers.
Related Services
- CDSCO Registration — Drug registration for products containing controlled substances
- DGFT Approvals — Trade facilitation for pharmaceutical imports/exports
- Pharmacovigilance — Safety monitoring for narcotic-containing pharmaceuticals
- NPPA Compliance — Pricing regulations for controlled substance formulations